Cargando…
Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer
While measurement of serum prostate specific antigen (PSA) is an important screening tool for prostate cancer, new biomarkers are necessary for better discrimination between presence and absence of disease. The MIL-38 monoclonal antibody is specific for the membrane glycoprotein glypican 1 (GPC-1) a...
Autores principales: | Campbell, Douglas H., Lund, Maria E., Nocon, Aline L., Cozzi, Paul J., Frydenberg, Mark, De Souza, Paul, Schiller, Belinda, Beebe-Dimmer, Jennifer L., Ruterbusch, Julie J., Walsh, Bradley J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908171/ https://www.ncbi.nlm.nih.gov/pubmed/29672570 http://dx.doi.org/10.1371/journal.pone.0196017 |
Ejemplares similares
-
Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker
por: Levin, Rachel A., et al.
Publicado: (2018) -
Targeted beta therapy of prostate cancer with (177)Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)
por: Yeh, Mei-Chun, et al.
Publicado: (2020) -
Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization
por: Truong, Quach, et al.
Publicado: (2016) -
Somatic glypican 3 (GPC3) mutations in Wilms' tumour
por: White, G R M, et al.
Publicado: (2002) -
Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis
por: Sun, Bin, et al.
Publicado: (2017)